# Fibrolamellar Hepatocellular Carcinoma (FLHCC) in a Young Patient Presenting With Nausea and Vomiting After a Greasy Meal

**Authors:** Mohamed Ismail, Sahiba Singh, Menna-Allah Elaskandrany, David s Kim, Yazan Abboud, Michael Bebawy, Abena Oduro, Ritik mahaveer Goyal, Omar Mohamed, Weizheng Wang

PMC · DOI: 10.7759/cureus.55863 · Cureus · 2024-03-09

## TL;DR

A 38-year-old man with no liver disease history was diagnosed with rare liver cancer after presenting with nausea and vomiting following a fatty meal.

## Contribution

Highlights a rare presentation of FLHCC and emphasizes the need for thorough evaluation in young patients with hepatic lesions.

## Key findings

- FLHCC was diagnosed in a young patient without underlying liver disease through biopsy after nonspecific symptoms.
- Successful surgical resection was performed with postoperative stability at six months.
- The case underscores the importance of considering FLHCC in differential diagnoses for hepatic lesions in young individuals.

## Abstract

Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare and distinct subtype of liver cancer, predominantly affecting younger patients without underlying liver diseases. This case report discusses a unique presentation of FLHCC in a 38-year-old male with a past medical history of a well-controlled seizure disorder.

The patient presented with nausea, vomiting, and abdominal pain following a fatty meal. Laboratory tests revealed elevated liver enzymes and anemia, and imaging showed a large hepatic lesion. Initial management included a septic workup and broad-spectrum antibiotics. However, a liver biopsy performed subsequently revealed the presence of FLHCC. The patient underwent a successful open right hepatectomy and was managed postoperatively with consideration of his seizure disorder. Follow-up at six months showed a stable postoperative condition without any evidence of recurrence.

The diagnosis of FLHCC is challenging due to its rarity and nonspecific presentation. The case emphasizes the importance of considering FLHCC in the differential diagnosis of hepatic lesions, particularly in young patients. Surgical resection remains the primary treatment modality.

This case underscores the importance of a thorough evaluation of hepatic lesions, especially in younger patients. It also illustrates the complexities in managing patients with FLHCC, requiring a multidisciplinary approach for optimal outcomes. Further research is necessary to better understand the pathogenesis of FLHCC and to develop more effective treatment strategies.

## Linked entities

- **Diseases:** Fibrolamellar Hepatocellular Carcinoma (MONDO:0006210), seizure disorder (MONDO:0005027)

## Full-text entities

- **Diseases:** hepatic lesion (MESH:D056486), Vomiting (MESH:D014839), liver diseases (MESH:D008107), septic (MESH:D001170), seizure disorder (MESH:D004827), Nausea (MESH:D009325), FLHCC (MESH:C537258), liver cancer (MESH:D006528), anemia (MESH:D000740), abdominal pain (MESH:D015746)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11002470/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11002470/full.md

## References

16 references — full list in the complete paper: https://tomesphere.com/paper/PMC11002470/full.md

---
Source: https://tomesphere.com/paper/PMC11002470